Page 884 - Robbins Basic Pathology by Vinay Kumar, Abul K. Abbas, Jon C. Aster
P. 884
870 C H A P T E R 23 Skin multiple mutations in specific pathways are required for malignant
transformation.]
Ibrahim N, Haluska FG: Molecular pathogenesis of cutaneous mela- Tsai KY, Tsao H: The genetics of skin cancer. Am J Med Genet 131C:82,
nocytic neoplasms. Annu Rev Pathol 4:551, 2009. [The genetic path- 2004. [The genetic bases for skin malignancies are presented along with
ways relevant to melanoma suggest future therapeutic interventions.] their associations with predisposing human genetic syndromes that provide
insight into their pathogenesis.]
Kupper TS, Fuhlbrigge RC: Immune surveillance in the skin: mecha- Ujiie H, Shibaki A, Nishie W, Shimizu H. What’s new in bullous pemphigoid.
nisms and clinical consequences. Nat Rev 4:211, 2004. [Lymphocytic J Dermatol 37:194, 2010. [Recent review of bullous pemphigoid
subtypes and targeting in relation to cutaneous inflammatory diseases pathogenesis.]
providing insight into common pathogenic features.] Yokoyama T, Amagai M. Immune dysregulation of pemphigus in
humans and mice. J Dermatol 37:205, 2010. [A review of immune
Nestle FO, Kaplan DH, Barker J: Psoriasis. N Engl J Med 361:496, 2009. disturbances that may underlie pemphigus.]
[Pathogenesis, clinical features, and new targeted treatment options are
discussed.]
Khavari PA: Modelling cancer in human skin tissue. Nat Rev Cancer
6:270, 2006. [Models of human epidermal carcinogenesis indicate that